NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
Stock Information for NanoViricides Inc.
Loading
Please wait while we load your information from QuoteMedia.